Clinerion and Patient iP partner to improve patient data insights

Clinerion and Patient iP partner to improve patient data insights

Real-world data solutions firm Clinerion, which focuses on improving efficiency in clinical trials, and health data and analytics company Patient iP, which provides patient data insights in order to accelerate and transform clinical research in the US, are collaborating to improve clinical trial design, site selection and patient enrolment. The companies will use Clinerion’s intelligent, patented Patient Network Explorer platform and Patient iP’s proprietary daTAscape asset to better target clinical trial sites and accelerate trial enrolment worldwide.

“Patient iP and Clinerion, as alliance partners, are a partnership of providers providing similar services, with a complementary geographic footprint. The creation of a network of Clinerion alliance partners establishes a new, global and comprehensive, service resource for actionable patient data insights for clinical research,” said Ian Rentsch, CEO of Clinerion. “We are happy to bring the international footprint of our hospital network to the benefit of Patient iP’s clients. At the same time, this collaboration will broaden our current ability to service clients with real-world data from the USA. Our offerings complement each other well.”

“Patient iP is excited about the potential that a collaboration with Clinerion brings to the patient qualification space. Our combined focus on providing opportunities for the right patient at the right time creates a strength that is difficult to match,” said Michael Margiotta, Chairman, Founder and CEO of Patient iP. “Our complementary technologies and global reach will now enable both Patient iP and Clinerion to view patient populations from a much more diverse and inclusive perspective than we are able to do independently of each other and thus service our customers better than ever.”